Psychiatry and Neurology, Neurology · Pasadena, CA
NPI
1225226301
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
139 S Los Robles Ave Unit B020
Pasadena, CA, 91101
Phone (626) 626-7670
Groups this clinician bills Medicare through
Medicare paid, 2024
$909K
46,450 services
Medicare patients, 2024
532
Average age 75
Drug cost, 2024
$8.9M
9,443 prescriptions
Company payments, 2025
$1,333
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon Yegiaian was code J0585 (injection, onabotulinumtoxina, 1 unit), 8,775 times for 26 patients. In total Sharon Yegiaian billed 46,450 services in 93 codes, and Medicare paid $909K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 8,775 | 26 | $4.99 | $44K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 2,951 | 11 | $4.09 | $12K |
| 99424 Chronic, Principal, and Transitional Care Management | Office | 2,624 | 385 | $68.55 | $180K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,415 | 176 | $51.73 | $73K |
| 99451 E&M - Miscellaneous | Office | 994 | 336 | $26.06 | $26K |
| 99215 Office E&M - Established | Office | 939 | 337 | $144.64 | $136K |
| 99422 Office/Outpatient Services | Office | 735 | 293 | $22.81 | $17K |
| 99423 E&M - Miscellaneous | Office | 517 | 239 | $36.22 | $19K |
| 96366 Intravenous Infusion, Hydration | Office | 503 | 11 | $18.19 | $9,150 |
| 99442 Telephone Services | Office | 445 | 219 | $75.57 | $34K |
| 99421 Office/Outpatient Services | Office | 357 | 215 | $12.88 | $4,600 |
| 99214 Office E&M - Established | Office | 266 | 170 | $102.90 | $27K |
| 99441 Telephone Services | Office | 245 | 170 | $47.51 | $12K |
| 90868 Treatment - Miscellaneous | Office | 244 | 12 | $105.88 | $26K |
| 99452 E&M - Miscellaneous | Office | 184 | 110 | $26.40 | $4,858 |
By year: 2022 $838K for 21,607 services; 2023 $679K for 16,595 services; 2024 $909K for 46,450 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 12 | 11 | $3.41 | $40.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Sharon Yegiaian prescribed most often to Medicare patients was Gabapentin, with 555 prescriptions and refills. In total Sharon Yegiaian wrote 9,443 Medicare prescriptions that cost $8.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 555 | 699 | 92 | $5,791 |
| Rytary Carbidopa/Levodopa | 250 | 260 | 32 | $174K |
| Valacyclovir Valacyclovir Hcl | 242 | 292 | 57 | $12K |
| Midodrine Hcl Generic | 240 | 290 | 43 | $11K |
| Memantine Hcl Generic | 229 | 262 | 33 | $2,854 |
| Propranolol Hcl Er Propranolol Hcl | 227 | 335 | 34 | $7,743 |
| Nortriptyline Hcl Generic | 218 | 241 | 53 | $2,221 |
| Atorvastatin Calcium Generic | 174 | 275 | 32 | $850 |
| Duloxetine Hcl Generic | 163 | 221 | 29 | $2,190 |
| Mirtazapine Generic | 141 | 170 | 31 | $2,509 |
| Pregabalin Generic | 136 | 147 | 27 | $2,501 |
| Famotidine Generic | 132 | 184 | 27 | $633 |
| Quetiapine Fumarate Generic | 131 | 149 | 23 | $2,776 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 130 | 130 | Under 11 | $2.9M |
| Amlodipine Besylate Generic | 117 | 175 | 23 | $441 |
Brand drugs: - claims; generic drugs: 7,813 claims; opioid claims: 64.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon Yegiaian $1,333 ($1,333 in general payments such as food, travel and fees) from 26 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $184.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $184 |
| Vertex Pharmaceuticals Incorporated VRTX | 5 | $145 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $113 |
| Pfizer Inc. PFE | 3 | $81.39 |
| Axsome Therapeutics, Inc. AXSM | 3 | $74.73 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $60.99 |
| Merz Pharmaceuticals, LLC | 2 | $57.07 |
| MDD US Operations, LLC | 2 | $53.66 |
| Lilly USA, LLC LLY | 2 | $51.3 |
| Argenx US, Inc. ARGX | 2 | $48.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.